Bio-Gate Overview

  • Founded
  • 2005
  • Status
  • Public
  • Employees
  • 30
  • Stock Symbol
  • BIG1
Stock Symbol
  • Share Price
  • $4.04
  • (As of Monday Closing)

Bio-Gate General Information


Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Stock Exchange
Primary Office
  • Neumeyerstraße 28-34
  • 90411 Nürnberg
  • Germany
+49 04775 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Gate Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.04 $4.07 $2.33 - $7.45 $27.7M 6.86M 319.51 -$0.14

Bio-Gate Financials Summary

In Thousands,
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 32,312 32,312 18,699 18,275
Revenue 5,850 5,850 3,904 4,353
EBITDA (592) (592) (834) (762)
Net Income (917) (917) (1,154) (1,023)
Total Assets 4,072 4,072 3,502 3,380
Total Debt 106 106 119 188
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bio-Gate Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bio-Gate‘s full profile, request access.

Request a free trial

Bio-Gate Executive Team (4)

Name Title Board Seat Contact Info
Marc Lloret-Grau Chief Executive Officer
Peter Steinrücke Director, Research & Development
Karl Richter Chairman
You’re viewing 3 of 4 executive team members. Get the full list »

Bio-Gate Board Members (5)

Name Representing Role Since
Karl Richter Bio-Gate Chairman 000 0000
Volker Alt Self Board Member 000 0000
You’re viewing 2 of 5 board members. Get the full list »

Bio-Gate Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Gate Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bio-Gate‘s full profile, request access.

Request a free trial